Neuroblastoma was defined in this study by clinical diagnosis, based on tumor biopsy results, catecholamine levels, and other systemic findings. Data collected included age at diagnosis ...

"Posie was diagnosed with Stage 2 neuroblastoma with associated Opsoclonus ... very similar to what Parkinson's looks like, and rapid eye movements. It was extremely scary, and it was debilitating.

The current findings build on 2008 studies by Maris's lab, one identifying the ALK gene as the major gene predisposing patients to the rare familial form of neuroblastoma, and the other ...

The findings, which offer insights that could potentially lead to new personalized medicine approaches in neuroblastoma treatment, were published today in the journal Nature Genetics. Despite ...

The findings, which offer insights that could potentially lead to new personalized medicine approaches in neuroblastoma treatment, were published today in the journal Nature Genetics. Despite ...

The study was primarily funded by Neuroblastoma UK and Cancer Research UK, and the findings were published in the journal Cancer Letters. Treatment needs to be more tailored Currently, all children ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric ...

The study marks the first time that researchers identified malignant cells responsible for relapse in neuroblastoma and offers insights for potential new therapeutic targets. The findings were ...

Lorlatinib appeared safe and showed potential efficacy among a cohort of patients with relapsed or refractory, ALK-driven, high-risk neuroblastoma, results of a phase 1 trial showed. The findings ...